In the BioHarmony Drug Report Database
Bethanechol
Urecholine (bethanechol) is a small molecule pharmaceutical. Bethanechol was first approved as Urecholine on 1982-01-01. It is used to treat drug-induced abnormalities, gastroesophageal reflux, neurogenic urinary bladder, and urinary retention in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M2 and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M5.
Trade Name
|
Urecholine |
|---|---|
Common Name
|
bethanechol |
ChEMBL ID
|
CHEMBL1482 |
Indication
|
drug-induced abnormalities, gastroesophageal reflux, neurogenic urinary bladder, urinary retention |
Drug Class
|
Image (chem structure or protein)